Study kills theory, discovers vitamin B not as helpful as thought against Alzheimer's

Vitamin B may be a general guardian of good health, but new research finds that it does little in the way of reducing the debilitating effects of Alzheimer's disease.

One of the many theories surrounding Alzheimer's disease concerns the level of the enzyme homocysteine in the body. Among Alzheimer's sufferers, the level is dramatically increased. Vitamin B has been shown to reduce the levels of homocysteine, and it was thought that doing so could ease the symptoms of Alzheimer's. According to the new research from the University of California, San Diego, however, that just isn't the case.

Researchers at the university randomly assigned vitamins B6 and B12 or a placebo to a group of 400 Alzheimer's patients. Over an 18-month follow-up period, they discovered that the vitamins had no significant effect on the level of cognitive decline in the patients. Experts in the field have said that this study puts an end to the idea that reducing homocysteine levels will ease Alzheimer's symptoms. The full report was published in the Wednesday's issue of the Journal of the American Medical Association.

More in News

Experts tell lawmakers: Obama's Medicare proposals would hurt long-term care — or maybe not

Experts tell lawmakers: Obama's Medicare proposals would hurt ...

U.S. lawmakers heard mixed messages at a hearing Tuesday on how proposed Medicare cost-sharing reforms would impact long-term care. The House Ways and Means Subcommittee on Health focused in particular ...

Nursing home administrators can rise to 'unrealistic expectations' with disaster management, expert ...

One day after a powerful tornado destroyed a hospital and devastated an Oklahoma town, long-term care stakeholders gathered at a disaster preparedness conference organized by the Center for Preparedness Education, a joint endeavor of the Creighton University School of Medicine and the University of Nebraska ...

Long-term care physicians respond to report on antipsychotic over-prescribing

The top professional association of long-term care physicians and medical directors has reiterated its commitment to reducing the use of antipsychotics for dementia care. It did so Tuesday, in response to a recent report that criticized prescribing practices.